From: The quality of primary care provided to the elderly in Israel
 | Denominator | Numerator | Rate | |
---|---|---|---|---|
Influenza vaccination | ||||
 Total | 879,671 | 556,355 | 63.25% | |
 Gender* | Male | 385,492 | 252,918 | 65.61% |
Female | 494,179 | 303,437 | 61.40% | |
 SEP | Low | 340,395 | 215,794 | 63.40% |
Middle & High | 539,276 | 340,561 | 63.15% | |
 Age* | 65–74 | 488,997 | 290,925 | 59.49% |
75–84 | 283,209 | 192,595 | 68.00% | |
85 or above | 107,465 | 72,835 | 67.78% | |
Pneumococcal vaccination | ||||
 Total | 449,274 | 346,032 | 77.02% | |
 Gender* | Male | 208,638 | 164,901 | 79.04% |
Female | 240,636 | 181,131 | 75.27% | |
 SEP* | Low | 136,138 | 110,501 | 81.17% |
Middle & High | 313,136 | 235,531 | 75.22% | |
 Age | 65–74 | 449,274 | 346,032 | 77.02% |
75–84 | NA | NA | NA | |
85 or above | NA | NA | NA | |
Benzodiazepine overuse | ||||
 Total | 879,671 | 45,858 | 5.21% | |
 Gender* | Male | 385,492 | 15,402 | 4.00% |
Female | 494,179 | 30,456 | 6.16% | |
 SEP* | Low | 340,395 | 23,841 | 7.00% |
Middle & High | 539,276 | 22,017 | 4.08% | |
 Age* | 65–74 | 488,997 | 14,567 | 2.98% |
75–84 | 283,209 | 18,946 | 6.69% | |
85 or above | 107,465 | 12,345 | 11.49% | |
Long-term benzodiazepine | ||||
 Total | 879,671 | 21,469 | 2.44% | |
 Gender* | Male | 385,492 | 7801 | 2.02% |
Female | 494,179 | 13,668 | 2.77% | |
 SEP* | Low | 340,395 | 9039 | 2.66% |
Middle & High | 539,276 | 12,430 | 2.30% | |
 Age* | 65–74 | 488,997 | 10,949 | 2.24% |
75–84 | 283,209 | 7668 | 2.71% | |
85 or above | 107,465 | 2852 | 2.65% | |
BMI documentation | ||||
 Total | 770,565 | 623,731 | 80.94% | |
 Gender* | Male | 345,894 | 281,149 | 81.28% |
Female | 424,671 | 342,582 | 80.67% | |
 SEP* | Low | 266,803 | 221,828 | 83.14% |
Middle & High | 503,762 | 401,903 | 79.78% | |
 Age* | 65–74 | 485,473 | 386,987 | 79.71% |
75–84 | 284,963 | 236,744 | 83.08% | |
85 or above | NA | NA | NA | |
Underweight | ||||
Total | 703,827 | 90,632 | 12.88% | |
 Gender* | Male | 312,365 | 36,537 | 11.70% |
Female | 391,462 | 54,095 | 13.82% | |
 SEP* | Low | 257,456 | 31,455 | 12.22% |
Middle & High | 446,371 | 59,177 | 13.26% | |
 Age* | 65–74 | 386,936 | 43,546 | 11.25% |
75–84 | 237,614 | 30,753 | 12.94% | |
85 or above | 79,277 | 16,333 | 20.60% | |
Weight loss | ||||
 Total | 613,408 | 37,673 | 6.14% | |
 Gender* | Male | 272,010 | 14,968 | 5.50% |
Female | 341,398 | 22,705 | 6.65% | |
 SEP* | Low | 222,945 | 15,613 | 7.00% |
Middle & High | 390,463 | 22,060 | 5.65% | |
 Age* | 65–74 | 320,649 | 16,165 | 5.04% |
75–84 | 221,014 | 14,915 | 6.75% | |
85 or above | 71,745 | 6593 | 9.19% |